Trial intelligence / Profile preview

Dexpanthenol for Prevention of Angular Cheilitis in Pediatric Adenotonsillectomy

NCT07002632Completed

Sponsor
Gaziosmanpaşa Training and Research Hospital
Start
Jul 2021
Primary completion
Jun 2024
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, open-label trial of dexpanthenol in angular cheilitis (AC) (2 arms), sponsored by Gaziosmanpaşa Training and Research Hospital. Primary endpoint: Incidence of Angular Cheilitis. Started Jul 2021; status: completed.

02

Drugs

dexpanthenol
03

Conditions

angular cheilitis (AC)

Beyond the preview

Go deeper on NCT07002632.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07002632.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call